293 related articles for article (PubMed ID: 19572349)
1. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
Zettl H; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
[No Abstract] [Full Text] [Related]
2. [The anti-platelet aggregation drugs: new approaches based on snake venom polypeptides].
Marrakchi N; Guermazi S; El Ayeb M
Arch Inst Pasteur Tunis; 1997; 74(1-2):9-15. PubMed ID: 15945171
[No Abstract] [Full Text] [Related]
3. [Pharmazie in unserer Zeit 4/2009].
Alban S; Dingermann T
Pharm Unserer Zeit; 2009; 38(4):295. PubMed ID: 19572344
[No Abstract] [Full Text] [Related]
4. [Antagonists of platelet P2 receptors: achievements, problems, and prospects].
Ziganshin AY
Eksp Klin Farmakol; 2010 Apr; 73(4):38-43. PubMed ID: 20486559
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological approaches to studying platelet function: an overview.
Hourani SM
Methods Mol Biol; 2004; 273():73-86. PubMed ID: 15308794
[No Abstract] [Full Text] [Related]
6. Antiplatelet drugs.
Born G; Patrono C
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S241-51. PubMed ID: 16402110
[No Abstract] [Full Text] [Related]
7. Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Patrono C; Coller B; Dalen JE; FitzGerald GA; Fuster V; Gent M; Hirsh J; Roth G
Chest; 2001 Jan; 119(1 Suppl):39S-63S. PubMed ID: 11157642
[No Abstract] [Full Text] [Related]
8. Platelet function testing and implications for clinical practice.
Collet JP; Montalescot G
J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
[TBL] [Abstract][Full Text] [Related]
9. Preoperative stop or continue? New antithrombotic and anticoagulants.
Ickx BE
Acta Anaesthesiol Belg; 2001; 52(4):385-93. PubMed ID: 11799571
[No Abstract] [Full Text] [Related]
10. Pharmacological control of platelet function.
Clutton P; Folts JD; Freedman JE
Pharmacol Res; 2001 Oct; 44(4):255-64. PubMed ID: 11592859
[TBL] [Abstract][Full Text] [Related]
11. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
[No Abstract] [Full Text] [Related]
12. Comparison of three arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet aggregation.
Weiss DJ; Evanson OA
J Vet Pharmacol Ther; 2004 Oct; 27(5):377-9. PubMed ID: 15500578
[No Abstract] [Full Text] [Related]
13. [Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
Drouet L
Rev Prat; 2007 Nov; 57(18):2045-50. PubMed ID: 18326440
[No Abstract] [Full Text] [Related]
14. Effects of anticoagulants used during blood collection on human platelet function.
May JA; Heptinstall S
Methods Mol Biol; 2004; 272():3-11. PubMed ID: 15226530
[No Abstract] [Full Text] [Related]
15. Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
Gruel Y; Lermusiaux P; Lang M; Darnige L; Rupin A; Delahousse B; Guilmot JL; Leroy J
Ann Vasc Surg; 1991 Nov; 5(6):552-5. PubMed ID: 1722991
[TBL] [Abstract][Full Text] [Related]
16. Platelet function inhibitors in the Year 2000.
Bennett JS; Mousa S
Thromb Haemost; 2001 Mar; 85(3):395-400. PubMed ID: 11307803
[No Abstract] [Full Text] [Related]
17. Thienopyrimidine-based P2Y12 platelet aggregation inhibitors.
Kortum SW; Lachance RM; Schweitzer BA; Yalamanchili G; Rahman H; Ennis MD; Huff RM; TenBrink RE
Bioorg Med Chem Lett; 2009 Oct; 19(20):5919-23. PubMed ID: 19748783
[TBL] [Abstract][Full Text] [Related]
18. Platelet-active drugs: the relationships among dose, effectiveness, and side effects.
Patrono C; Coller B; Dalen JE; Fuster V; Gent M; Harker LA; Hirsh J; Roth G
Chest; 1998 Nov; 114(5 Suppl):470S-488S. PubMed ID: 9822058
[No Abstract] [Full Text] [Related]
19. Inhibition of platelet activation and aggregation.
Ahrens I; Bode C; Peter K
Handb Exp Pharmacol; 2005; (170):443-62. PubMed ID: 16596810
[TBL] [Abstract][Full Text] [Related]
20. [Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Rhyner K; Stenger M; Block LH
Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1211-4. PubMed ID: 6430669
[No Abstract] [Full Text] [Related]
[Next] [New Search]
